217 related articles for article (PubMed ID: 27697495)
1. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
Gentile E; Liuzzi GM
Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
[TBL] [Abstract][Full Text] [Related]
2. Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors.
Thomas NV; Monica Diyya AS; Kim SK; Faraj KA; Ghafoor DD; Qian ZJ; Tigabu BM
Curr Pharm Des; 2022; 28(41):3351-3362. PubMed ID: 36411577
[TBL] [Abstract][Full Text] [Related]
3. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase inhibitors: a patent review (2011 - 2013).
Li NG; Tang YP; Duan JA; Shi ZH
Expert Opin Ther Pat; 2014 Sep; 24(9):1039-52. PubMed ID: 25098768
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.
Zhang C; Kim SK
Mar Drugs; 2009 Mar; 7(2):71-84. PubMed ID: 19597572
[TBL] [Abstract][Full Text] [Related]
7. Metalloproteinases and their inhibitors in neurological disease.
Lopez-Navarro ER; Gutierrez J
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jan; 395(1):27-38. PubMed ID: 34851449
[TBL] [Abstract][Full Text] [Related]
8. Potential matrix metalloproteinase inhibitors from edible marine algae: a review.
Thomas NV; Manivasagan P; Kim SK
Environ Toxicol Pharmacol; 2014 May; 37(3):1090-100. PubMed ID: 24780533
[TBL] [Abstract][Full Text] [Related]
9. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma.
Fields GB
Cells; 2019 Aug; 8(9):. PubMed ID: 31461880
[TBL] [Abstract][Full Text] [Related]
10. Seesaw of matrix metalloproteinases (MMPs).
Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase enzymes and their naturally derived inhibitors: novel targets in photocarcinoma therapy.
Gupta A; Kaur CD; Jangdey M; Saraf S
Ageing Res Rev; 2014 Jan; 13():65-74. PubMed ID: 24355347
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
[TBL] [Abstract][Full Text] [Related]
13. Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.
Baidya SK; Banerjee S; Adhikari N; Jha T
J Med Chem; 2022 Aug; 65(16):10709-10754. PubMed ID: 35969157
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
Lively TJ; Bosco DB; Khamis ZI; Sang QX
Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
Shi Y; Ma X; Fang G; Tian X; Ge C
NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
Yang JS; Lin CW; Su SC; Yang SF
Expert Opin Drug Metab Toxicol; 2016; 12(2):191-200. PubMed ID: 26852787
[TBL] [Abstract][Full Text] [Related]
17. MMP inhibitors and cancer treatment trials, limitations and hopes for the future.
Tlatli R; El Ayeb M
Arch Inst Pasteur Tunis; 2013; 90(1-4):3-21. PubMed ID: 26012207
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases: potential therapeutic target for diabetic neuropathic pain.
Kuhad A; Singh P; Chopra K
Expert Opin Ther Targets; 2015 Feb; 19(2):177-85. PubMed ID: 25243524
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]